Confirmed mpox clade Ib case in Germany, risk remains low for EU/EEA
The European Centre for Disease Prevention and Control (ECDC) is aware of the recent confirmation of the first mpox clade Ib case in Germany and is monitoring the situation closely. The case was acquired abroad and detected on Friday, 18 October 2024.
ECDC previously issued a risk assessment on mpox clade 1 on 16 August 2024, highlighting the likelihood of further imported clade I mpox cases due to close travel links between Europe and Africa. While the risk of sustained transmission of mpox in Europe remains low, ECDC advises enhanced preparedness, continued vigilance and rapid implementation of control measures upon case detection.
Travellers to areas affected by the mpox outbreak should consult their healthcare provider or travel health clinic regarding eligibility for vaccination against mpox. Additionally, it is important to note that close physical contact is necessary to transmit the mpox virus. Individuals should be aware of the symptoms, which include a rash, fever, headache, and muscle pain, and seek medical attention if they experience these symptoms.
ECDC, working closely with its international partners, continues to monitor the situation closely and will adapt its recommendations as needed.
